Correlation Analysis
ABBVIE INC. vs Oracle Corp
ABBV vs ORCL
+0.784
Strong positive
When one moves up, the other tends to follow.
ABBVIE INC.
↗ABBV
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Market cap 365.6B
Oracle Corp
↗ORCL
Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world's largest companies for high-volume online transaction processing workloads. Besides databases, Oracle also sells enterprise resource planning platforms and cloud infrastructure that play an increasingly important role in large language model training and inferencing.
Market cap 418.6B
Time Series
Relative Performance
Who Moves First
ORCL leads ABBV by 6 days
ORCL tends to move before ABBV.
After testing 13 timing shifts, the strongest relationship was +0.795 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
+0.050
16 periods · Return correlation when both series rose
Both Falling
-0.787
8 periods · Return correlation when both series fell
Diverging
-0.593
11 periods · Return correlation when series moved apart
R-Squared
61.5%
Share of variance in one series explained by the other.
Trend Agreement
54.3%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,254
Deep shared window — 1,254 usable pairs.
Significance
p < 0.001
95% CI: [0.762, 0.805]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,254 paired data points survived the daily window.
Raw input
1,254
1,254
Normalized
1,254
1,254
Prepared
1,254
1,254
Aligned
1,254
1,254
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
0
A: 0 / B: 0
Series A
ABBVIE INC.
ABBV
Market cap 365.6B
Stock · 1,254 raw → 1,254 prepared
Series B
Oracle Corp
ORCL
Market cap 418.6B
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
29
Estimated crossover points between normalized spreads.
Slope
1.2743
Linear regression slope.
Intercept
-82.5003
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 7 hours ago · ID: stock-abbv-vs-stock-orcl-daily